JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

Strona główna・Stock List・Pliant Therapeutics Inc

Pliant Therapeutics Inc

Closed

1.09 -6.84

Buy Sell

Overview

Share price change

24h

Current

Min

1.09

Max

1.19

Key metrics
By Trading Economics
Income	17M -26M
Employees	171
EBITDA	19M -23M

Recommendations
By TipRanks
Recommendations	Sell
12 Months Forecast	+238.98% upside

Dividends
By Dow Jones
Next Earnings	26 lut 2026

Market Stats
By TradingEconomics
Market Cap	-29M 73M
Previous open	7.93
Previous close	1.09

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

1.43 / 1.6 Support & Resistance

Pliant Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

5 lut 2026, 23:57 UTC

Earnings

Naver Has Record Year Despite Weaker Final Quarter

5 lut 2026, 23:45 UTC

Hot Stocks

Stocks to Watch: Amazon, Coty, Gen Digital, Roblox

5 lut 2026, 22:26 UTC

Earnings

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9% -- Update

5 lut 2026, 22:00 UTC

Earnings

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9%

5 lut 2026, 23:47 UTC

Market Talk

Global Equities Roundup: Market Talk

5 lut 2026, 23:47 UTC

Market Talk

Nikkei May Fall After U.S. Tech Stock Drops -- Market Talk

5 lut 2026, 23:43 UTC

Market Talk

Gold Falls on Spillover Impact From Cryptocurrencies' Selloff -- Market Talk

5 lut 2026, 23:37 UTC

Market Talk

Glencore Shares Look Cheap After Failed Takeover Talks -- Market Talk

5 lut 2026, 23:20 UTC

Earnings

Acquisitions, Mergers, Takeovers

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 5th Update

5 lut 2026, 23:11 UTC

Market Talk

Amazon CEO Confident in Return on $200B Investment -- Market Talk

5 lut 2026, 23:09 UTC

Earnings

Naver 2025 Net KRW1.820T Vs. Net KRW1.932T >035420.SE

5 lut 2026, 23:08 UTC

Earnings

Naver 2025 Oper Pft KRW2.208T Vs. Pft KRW1.979T >035420.SE

5 lut 2026, 23:07 UTC

Earnings

Naver 2025 Rev KRW12.035T Vs. KRW10.738T >035420.SE

5 lut 2026, 23:03 UTC

Market Talk

Earnings

REA's Update Looks Negative Despite A$200M Buyback -- Market Talk

5 lut 2026, 23:03 UTC

Earnings

Acquisitions, Mergers, Takeovers

Bitcoin Booster's $12 Billion Loss Headlines Crypto's Worst Day Since 2022 Crash -- WSJ

5 lut 2026, 23:00 UTC

Earnings

Naver 4Q Net Profit Missed FactSet-Compiled Consensus

5 lut 2026, 23:00 UTC

Earnings

Naver 4Q Net KRW164.60B Vs. Net KRW514.00B >035420.SE

5 lut 2026, 22:59 UTC

Earnings

Naver 4Q Oper Pft KRW610.60B Vs. Pft KRW542.00B >035420.SE

5 lut 2026, 22:59 UTC

Earnings

Naver 4Q Rev KRW3.195T Vs. KRW2.886T >035420.SE

5 lut 2026, 22:52 UTC

Earnings

Alphabet Stock Is Taking a Hit After Strong Earnings. Don't Panic. -- Barrons.com

5 lut 2026, 22:45 UTC

Earnings

Amazon Stock Falls Sharply on Earnings. Spending Continues to Soar. -- Barrons.com

5 lut 2026, 22:37 UTC

Market Talk

Woolworths's Profit Margin Likely Faces 2Q Squeeze -- Market Talk

5 lut 2026, 22:11 UTC

Earnings

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9% -- Update

5 lut 2026, 22:03 UTC

Earnings

Acquisitions, Mergers, Takeovers

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 4th Update

5 lut 2026, 22:01 UTC

Earnings

Reddit Stock Jumps on Earnings. CFO Cites Modest AI Spending. -- Barrons.com

5 lut 2026, 21:59 UTC

Market Talk

Acquisitions, Mergers, Takeovers

What's Next For Rio Tinto, Glencore After Deal Talks Fail? -- Market Talk

5 lut 2026, 21:51 UTC

Earnings

Acquisitions, Mergers, Takeovers

Saylor's Strategy Posts $12 Billion Quarterly Loss on Bitcoin Selloff -- WSJ

5 lut 2026, 21:50 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Basic Materials Roundup: Market Talk

5 lut 2026, 21:49 UTC

Earnings

Why Google's Bad News Was Good News for Broadcom and Nvidia -- Barrons.com

5 lut 2026, 21:45 UTC

Earnings

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9%

Peer Comparison

Price change

Pliant Therapeutics Inc Forecast

Price Target

By TipRanks

238.98% upside

12 Months Forecast

Average 4 USD 238.98%

High 4 USD

Low 4 USD

Based on 3 Wall Street analysts offering 12 month price targets forPliant Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Sell

3 ratings

Buy

Hold

Sell

Based on 3 analysts giving stock ratings to Pliant Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

1.43 / 1.6Support & Resistance

Recent bearish events outweigh bullish events.

There is one bearish event.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.